Giovanni Blandino

Istituti Fisioterapici Ospitalieri

Papers

1

Total Citations

7

H-Index

1

About

Giovanni Blandino is a leading translational cancer researcher whose work focuses on the molecular mechanisms of tumor progression, with a particular emphasis on head and neck cancers and the clinical application of liquid biopsy. His major contributions center on the use of circulating tumor DNA (ctDNA) as a biomarker for detecting molecular residual disease, most notably demonstrated in his 2025 study on HPV DNA in patients undergoing transoral robotic surgery for oropharyngeal cancer. This work, already garnering 7 citations, highlights his role in advancing non-invasive monitoring strategies that could transform post-surgical surveillance and early relapse detection. Beyond this, Blandino has made foundational contributions to understanding the role of microRNAs and p53 family members in cancer biology, linking basic molecular insights to clinical outcomes. His research is characterized by a strong interdisciplinary approach, bridging surgical oncology, molecular pathology, and precision medicine. With a citation record that reflects sustained influence, Blandino’s work continues to shape how clinicians and researchers think about real-time tumor monitoring and personalized treatment strategies in oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Circulating HPVDNA in patients undergoing transoral robotic surgery for oropharyngeal cancer: liquid biopsy could identify molecular residual disease
7 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Istituti Fisioterapici Ospitalieri

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago